Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2024-2028

PUBLISHED: July 24, 2024

PAGES: 156 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The ibuprofen active pharmaceutical ingredient (API) market is forecasted to grow by USD 26.3 mn during 2023-2028, accelerating at a CAGR of 2.08% during the forecast period. The report on the ibuprofen active pharmaceutical ingredient (API) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population, evolving API manufacturing scenario in developing countries, and increase in pharmaceutical and biopharmaceutical production.

Technavio's ibuprofen active pharmaceutical ingredient (API) market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	2.02%
CAGR	2.08%
Incremental Value	$26.3 mn

By End-user

Pharmaceutical companies
Contract manufacturing organizations

By Product

Prescription
Over-the-counter

By Geographical Landscape

Asia
North America
Europe
Rest of World (ROW)

This study identifies the paradigm shift in API manufacturing as one of the prime reasons driving the ibuprofen active pharmaceutical ingredient (API) market growth during the next few years. Also, increase in r and d investments by ibuprofen API manufacturers and increase number of CEP approval for manufacture of ibuprofen API will lead to sizable demand in the market.

The report on the ibuprofen active pharmaceutical ingredient (API) market covers the following areas:

Ibuprofen active pharmaceutical ingredient (API) market sizing
Ibuprofen active pharmaceutical ingredient (API) market forecast
Ibuprofen active pharmaceutical ingredient (API) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ibuprofen active pharmaceutical ingredient (API) market vendors that include Arch Pharmalabs Ltd., Athos Chemicals Pvt. Ltd., Azelis SA, BASF SE, Chemino Pharma Ltd., DR Reddys Laboratories Ltd., Granules India Ltd., HELM AG, IOL Chemicals and Pharmaceuticals Ltd., Mallinckrodt PLC, Octavius Pharma Pvt. Ltd., Otto Brandes GmbH, Piramal Enterprises Ltd., Rochem International Inc., SI Group Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd., Solara Active Pharma Sciences Ltd, Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., and Titan LAB Pvt Ltd.. Also, the ibuprofen active pharmaceutical ingredient (API) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR75040

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2018 - 2022
- Historic Market Size - Data Table on Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2018 - 2022 ($ million)
4.2 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
6.3 Pharmaceutical companies - Market size and forecast 2023-2028
- Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
- Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
- Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
- Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
6.4 Contract manufacturing organizations - Market size and forecast 2023-2028
- Chart on Contract manufacturing organizations - Market size and forecast 2023-2028 ($ million)
- Data Table on Contract manufacturing organizations - Market size and forecast 2023-2028 ($ million)
- Chart on Contract manufacturing organizations - Year-over-year growth 2023-2028 (%)
- Data Table on Contract manufacturing organizations - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

7.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
7.3 Prescription - Market size and forecast 2023-2028
- Chart on Prescription - Market size and forecast 2023-2028 ($ million)
- Data Table on Prescription - Market size and forecast 2023-2028 ($ million)
- Chart on Prescription - Year-over-year growth 2023-2028 (%)
- Data Table on Prescription - Year-over-year growth 2023-2028 (%)
7.4 Over-the-counter - Market size and forecast 2023-2028
- Chart on Over-the-counter - Market size and forecast 2023-2028 ($ million)
- Data Table on Over-the-counter - Market size and forecast 2023-2028 ($ million)
- Chart on Over-the-counter - Year-over-year growth 2023-2028 (%)
- Data Table on Over-the-counter - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.4 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.5 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 Athos Chemicals Pvt. Ltd.
- Athos Chemicals Pvt. Ltd. - Overview
- Athos Chemicals Pvt. Ltd. - Product / Service
- Athos Chemicals Pvt. Ltd. - Key offerings
12.4 Azelis SA
- Azelis SA - Overview
- Azelis SA - Business segments
- Azelis SA - Key offerings
- Azelis SA - Segment focus
12.5 BASF SE
- BASF SE - Overview
- BASF SE - Business segments
- BASF SE - Key news
- BASF SE - Key offerings
- BASF SE - Segment focus
12.6 Chemino Pharma Ltd.
- Chemino Pharma Ltd. - Overview
- Chemino Pharma Ltd. - Product / Service
- Chemino Pharma Ltd. - Key offerings
12.7 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
12.8 Granules India Ltd.
- Granules India Ltd. - Overview
- Granules India Ltd. - Product / Service
- Granules India Ltd. - Key news
- Granules India Ltd. - Key offerings
12.9 IOL Chemicals and Pharmaceuticals Ltd.
- IOL Chemicals and Pharmaceuticals Ltd. - Overview
- IOL Chemicals and Pharmaceuticals Ltd. - Business segments
- IOL Chemicals and Pharmaceuticals Ltd. - Key offerings
- IOL Chemicals and Pharmaceuticals Ltd. - Segment focus
12.10 Octavius Pharma Pvt. Ltd.
- Octavius Pharma Pvt. Ltd. - Overview
- Octavius Pharma Pvt. Ltd. - Product / Service
- Octavius Pharma Pvt. Ltd. - Key offerings
12.11 Piramal Enterprises Ltd.
- Piramal Enterprises Ltd. - Overview
- Piramal Enterprises Ltd. - Product / Service
- Piramal Enterprises Ltd. - Key offerings
12.12 Rochem International Inc.
- Rochem International Inc. - Overview
- Rochem International Inc. - Product / Service
- Rochem International Inc. - Key offerings
12.13 SI Group Inc.
- SI Group Inc. - Overview
- SI Group Inc. - Product / Service
- SI Group Inc. - Key offerings
12.14 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd.
- Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Overview
- Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Product / Service
- Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Key offerings
12.15 Solara Active Pharma Sciences Ltd
- Solara Active Pharma Sciences Ltd - Overview
- Solara Active Pharma Sciences Ltd - Product / Service
- Solara Active Pharma Sciences Ltd - Key offerings
12.16 Strides Pharma Science Ltd.
- Strides Pharma Science Ltd. - Overview
- Strides Pharma Science Ltd. - Product / Service
- Strides Pharma Science Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
- 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR75040

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on End-user - Market share 2023-2028 (%)
Exhibits33: Data Table on End-user - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by End-user
Exhibits35: Data Table on Comparison by End-user
Exhibits36: Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Contract manufacturing organizations - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Contract manufacturing organizations - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Contract manufacturing organizations - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Contract manufacturing organizations - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by End-user ($ million)
Exhibits45: Data Table on Market opportunity by End-user ($ million)
Exhibits46: Chart on Product - Market share 2023-2028 (%)
Exhibits47: Data Table on Product - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Product
Exhibits49: Data Table on Comparison by Product
Exhibits50: Chart on Prescription - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Prescription - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Prescription - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Prescription - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Over-the-counter - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Over-the-counter - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Over-the-counter - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Over-the-counter - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by Product ($ million)
Exhibits59: Data Table on Market opportunity by Product ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: Athos Chemicals Pvt. Ltd. - Overview
Exhibits110: Athos Chemicals Pvt. Ltd. - Product / Service
Exhibits111: Athos Chemicals Pvt. Ltd. - Key offerings
Exhibits112: Azelis SA - Overview
Exhibits113: Azelis SA - Business segments
Exhibits114: Azelis SA - Key offerings
Exhibits115: Azelis SA - Segment focus
Exhibits116: BASF SE - Overview
Exhibits117: BASF SE - Business segments
Exhibits118: BASF SE - Key news
Exhibits119: BASF SE - Key offerings
Exhibits120: BASF SE - Segment focus
Exhibits121: Chemino Pharma Ltd. - Overview
Exhibits122: Chemino Pharma Ltd. - Product / Service
Exhibits123: Chemino Pharma Ltd. - Key offerings
Exhibits124: Dr Reddys Laboratories Ltd. - Overview
Exhibits125: Dr Reddys Laboratories Ltd. - Business segments
Exhibits126: Dr Reddys Laboratories Ltd. - Key news
Exhibits127: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits128: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits129: Granules India Ltd. - Overview
Exhibits130: Granules India Ltd. - Product / Service
Exhibits131: Granules India Ltd. - Key news
Exhibits132: Granules India Ltd. - Key offerings
Exhibits133: IOL Chemicals and Pharmaceuticals Ltd. - Overview
Exhibits134: IOL Chemicals and Pharmaceuticals Ltd. - Business segments
Exhibits135: IOL Chemicals and Pharmaceuticals Ltd. - Key offerings
Exhibits136: IOL Chemicals and Pharmaceuticals Ltd. - Segment focus
Exhibits137: Octavius Pharma Pvt. Ltd. - Overview
Exhibits138: Octavius Pharma Pvt. Ltd. - Product / Service
Exhibits139: Octavius Pharma Pvt. Ltd. - Key offerings
Exhibits140: Piramal Enterprises Ltd. - Overview
Exhibits141: Piramal Enterprises Ltd. - Product / Service
Exhibits142: Piramal Enterprises Ltd. - Key offerings
Exhibits143: Rochem International Inc. - Overview
Exhibits144: Rochem International Inc. - Product / Service
Exhibits145: Rochem International Inc. - Key offerings
Exhibits146: SI Group Inc. - Overview
Exhibits147: SI Group Inc. - Product / Service
Exhibits148: SI Group Inc. - Key offerings
Exhibits149: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Overview
Exhibits150: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Product / Service
Exhibits151: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Key offerings
Exhibits152: Solara Active Pharma Sciences Ltd - Overview
Exhibits153: Solara Active Pharma Sciences Ltd - Product / Service
Exhibits154: Solara Active Pharma Sciences Ltd - Key offerings
Exhibits155: Strides Pharma Science Ltd. - Overview
Exhibits156: Strides Pharma Science Ltd. - Product / Service
Exhibits157: Strides Pharma Science Ltd. - Key offerings
Exhibits158: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits159: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits160: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits161: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits162: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits163: Inclusions checklist
Exhibits164: Exclusions checklist
Exhibits165: Currency conversion rates for US$
Exhibits166: Research methodology
Exhibits167: Information sources
Exhibits168: Data validation
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Data synthesis
Exhibits171: 360 degree market analysis
Exhibits172: List of abbreviations